Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Triumeq shown to slow down progression of MND in mice

Dec. 21, 2020

Sage Therapeutics synthesizes CYP46A1 inhibitors

Dec. 21, 2020

Psychedelic analogue has therapeutic potential

Dec. 18, 2020

Pfizer studies PF-06939926 in phase III for DMD

Dec. 18, 2020

Through mTOR, ketamine affects protein translation hub

Dec. 17, 2020

Phase I data presented for cannabidivarin for treating epilepsy in patients with Rett syndrome

Dec. 17, 2020

Researchers develop a mitometin-testing murine model of ALS

Dec. 17, 2020

Topline data from phase II study of vocacapsaicin in total knee arthroplasty surgery

Dec. 17, 2020

Evaluation of the modafinil analogue (S,S)-CE-158 in neurochemical and behavioral studies in rats

Dec. 17, 2020

Shanghai Zhimeng Biopharma presents new KCNQ2 activators

Dec. 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...